| Epidemiology of acromegaly: review of population studies A Lavrentaki, A Paluzzi, JAH Wass, N Karavitaki Pituitary 20, 4-9, 2017 | 383 | 2017 |
| Recurrence of silent corticotroph adenomas after primary treatment: a systematic review and meta-analysis A Fountas, A Lavrentaki, A Subramanian, KA Toulis, K Nirantharakumar, ... The Journal of Clinical Endocrinology & Metabolism 104 (4), 1039-1048, 2019 | 53 | 2019 |
| MECHANISMS OF ENDOCRINOLOGY: Mechanisms of disease: the endocrinology of obstructive sleep apnoea A Lavrentaki, A Ali, BG Cooper, AA Tahrani European journal of endocrinology 180 (3), R91-R125, 2019 | 39 | 2019 |
| Early membrane initiated transcriptional effects of estrogens in breast cancer cells: First pharmacological evidence for a novel membrane estrogen receptor element (ERx) M Kampa, G Notas, V Pelekanou, M Troullinaki, M Andrianaki, K Azariadis, ... Steroids 77 (10), 959-967, 2012 | 35 | 2012 |
| Increased risk of non-alcoholic fatty liver disease in women with gestational diabetes mellitus: A population-based cohort study, systematic review and meta-analysis A Lavrentaki, T Thomas, A Subramanian, G Valsamakis, N Thomas, ... Journal of Diabetes and its Complications 33 (10), 107401, 2019 | 34 | 2019 |
| Accurate prediction of severe allergic reactions by a small set of environmental parameters (NDVI, temperature) G Notas, M Bariotakis, V Kalogrias, M Andrianaki, K Azariadis, ... PloS one 10 (3), e0121475, 2015 | 6 | 2015 |
| Gestational Diabetes Mellitus is associated with increased risk of Non-Alcoholic Fatty Liver Disease: A population-based cohort study A Lavrentaki, A Subramanian, GN Thomas, G Valsamakis, K Toulis, ... Endocrine Abstracts 56, 2018 | 1 | 2018 |
| The heterogeneous spectrum of adrenal ganglioneuromas: two interesting cases G Ntali, E Kardalas, M Markou, P Mouchtouris, E Partsalaki, A Lavrentaki, ... Endocrine Abstracts 94, 2023 | | 2023 |
| Endocrine Consequences Following Immune Checkpoint Inhibitors Therapy A Lavrentaki, G Ntali Handbook of Cancer and Immunology, 1-32, 2023 | | 2023 |
| Recent advances in understanding and managing pituitary adenomas M Markou, A Lavrentaki, G Ntali Faculty Reviews 12, 2023 | | 2023 |
| Bone metabolism and bone mass density following successful treatment of catecholamine secreting tumors E Kardalas, G Ntali, P Mouchtouris, A Papachristou, A Lavrentaki, ... Endocrine Abstracts 86, 2022 | | 2022 |
| Post-menopausal woman with adrenal incidentalomas and significantly elevated levels of 17-OH progesterone MV Ioanna, M Giannakou, E Kardalas, A Lavrentaki, P Mouchtouris, ... Endocrine Abstracts 75, 2021 | | 2021 |
| Mechanisms of endocrinology A Lavrentaki, A Ali, BG Cooper, AA Tahrani | | 2019 |
| Are silent corticotroph adenomas high risk tumours for recurrence? Systematic review and meta-analysis A Fountas, A Lavrentaki, A Subramanian, K Toulis, K Nirantharakumar, ... Endocrine Abstracts 59, 2018 | | 2018 |
| Gestational diabetes is associated with increased risk of non-alcoholic fatty liver disease: a population-based cohort study A Lavrentaki, A Subramanian, N Thomas, G Valsamakis, K Toulis, B Daly, ... 54th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD), 2018 | | 2018 |
| Correction: Accurate Prediction of Severe Allergic Reactions by a Small Set of Environmental Parameters (NDVI, Temperature) G Notas, M Bariotakis, V Kalogrias, M Andrianaki, K Azariadis, ... Plos one 10 (4), e0127604, 2015 | | 2015 |
| Increased Risk of Non-Alcoholic Fatty Liver Disease in Women with Gestational Diabetes Mellitus A Lavrentaki | | |
